|
| Main | | | | | | | | | | |
| Brand | Generic | Indication | MOA | | | | | | GlucoFi, Abmaxis - Q2 closing |
| | boceprevir | Hepatitis C | Protease | | | | | | |
| Cozaar/Hyzaar | losartan | Hypertension | ARB | 1 | 1995 | Feb 2010 | | | |
| Elonva | corifollitropin alfa | Fertility | | EU only? | Filed | Injectable | | | |
| Fosamax | | Osteoporosis | Biphosphonate | 1 | 2008 | | | | |
| Keytruda, fka MK-3475 | | | | | | | | | |
| Tredaptive | Dyslipidemia | | | 7/2007 | Oral | | | | |
| Vytorin/Inegy | | Dyslipidemia | Statin | 1 | 7/23/2004 | 2024, IPXL | | | |
| Zetia/Ezetrol | | Dyslipidemia | | 1 | 10/25/2002 | 2015/2016 | | | |
| Zolinza, fka SAHA | vorinostat | CTCL | HDAC | 1 | | | | | |
| Singulair | montelukast | Asthma, Allergic Rhinitis | Leukotriene | 1 | 2002 | 8/3/12 COM | | | |
| Zostavax | | Shingles | Vaccine | 1 | | Injectable | | | |
| Nexium | GERD, Heartburn | PPI | 27% US, AZN | | Generic 2014 | | | | |
| Saphris | Schizophrenia | Atypical | 100%? | ? | | | | | |
| Asmanex (mometasone) | Asthma | Steroid | 1 | 2005 | 2012-2018 | | | | |
| Vasotec | | | | | | | | | |
| Zontivity (vorapaxar) | ACS/MI | Thrombin Receptor | 1 | III | Oral | | | | |
| Cancidas (caspofungin) | Antifungal | Echinocandin | 1 | 2001 | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Failures | | | | | | | | | |
| MK-7009 | | Hepatitis C | Protease | | | | | | |
| MK-859 | anacetrapib | Dyslipidemia | CETP | | | | | | |
| MK2578 | | | | | | | | | |
| Betrixaban | | | | | | | | | |
| ANAC | | | | | | | | | |
| AVEO | | | | | | | | | |
| Cordaptive | | | | | | | | | |
| Cordaptive (MK-524A) | Niacin XR | Niacin | | | III | ABT/AZN combo | Oral | | |
| MK-524B | Niacin XR/Zocor | Niacin | | | III | | | | |
| MK-677 | ibutamoren | Fibromyalgia, Hip Fracture | GH secretagogue | 1 | III | | | | |
| MK-974 | telcagepant | Migraine Headache | Calcitonin (CGRP) | 1 | III | Oral | | | |
| odanacatib (MK-0882) | Osteoporosis, Oncology, Arthritis | Cathespin-K | CRA | III | | | | | |
| Lipitor+Zetia (0653C) | Dyslipidemia | Statin | 1 | Filed | | | | | |
| MK-8669 (ridaforolimus) | Sarcoma | MTOR | ARIA | III | | | | | |
| MK-0724 (ONO-2506) | Stroke | | | II | | | | | |
| MK-0646 | mCRC | IGF-1 | 1 | II/III | | | | | |
| MK-6213 | Dyslipidemia | | | | | | | | |
| narlaprevir | | | | | | | | | |
| MK-533 | Type 2 Diabetes | PPAR | | II | | | | | |
| MK-0140 | Ophthalmic | | | II | | | | | |
| MK-0752 | Cancer | NOTCH | 1 | I | | | | | |
| MK-2206 | Oncology | AKT | | I | | | | | |
| MK-1775 | | WEE1 | | I | | | | | |
| MK-4074 | Diabetes | ACC1 | | I | | | | | |
| MK-5108 | | Aurora kinase | VRTX? | I | | | | | |
| MK-634 | urinary incontinence | | | | | | | | |
| MK-3281 | Hepatitis C | Polymerase | 1 | | | | | | |
| MK-594 | urinary incontinence | | | | | | | | |